Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
CM-4620 is an inhibitor of Orai1/STIM1-containing store-operated calcium channels (SOCs; IC50 = 120 nM).1 It is selective for Orai1/STIM1-containing SOCs over Orai2/STIM2-containing SOCs (IC50 = 900 nM). CM-4620 (3 µM) decreases cholecystokinin- or taurolithocholic acid 3-sulfate-induced cell death in isolated mouse, rat, and human acini. In vivo, CM-4620 (20 mg/kg) reduces blood amylase and lipase levels and pancreatic trypsin activity in a mouse model of cerulein-induced acute pancreatitis.
WARNING This product is not for human or veterinary use.
1. The Orai Ca2+ channel inhibitor CM4620 targets both parenchymal and immune cells to reduce inflammation in experimental acute pancreatitis. J. Physiol. 597(12), 3085-3105 (2019).